1CHINNAIYAN K M, ALEXANDER D, MADDENS M, et al. Curriculum in cardiology: Integrated diagnosis and management of diastolic heart failure[J]. Am Heart J, 2007,153:189- 200.
2AHMED A, PERRY G J, FLEG J L, et al. Out comes in ambulatory chronic systolic and diastolic heart failure: A propensity score analysis[J]. Am Heart J,2006,152:956-966.
3ZILE M R. BRUTSAERT D L. New concepts in diastolic dysfunction and diastolic heart failure: part Ⅰ: Diagnosis, prognosis, and measurements of diastolic function[J]. Circulation,2002, 105: 1387-1393.
4HUNT S A, ABRAHAM W T, CHIN M H, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adul [J].Circulation, 2005,112:e154-e235.
5KRUM H, JEI.INEK M V, STEWART S, et al. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006[J]. Med J Aust, 2006,185: 549-556.
6European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure[J].Eur Heart J, 1998,19: 990-1003.
7VASAN R S, LEVY D. Defining diastolic heart failure: a call for standardized diagnostic criteria[J].Cir culation, 2000,101: 2118-2121.
8PIESKE B. Can brain natriuretic peptide be used to diagnose and manage patients with diastolic heart failure? [J]. Nat Clin Pract Cardiovasc Med, 2006,3:418 -419.
9LOGEART D, GAMBERT A, BEYNE P, et al. Brain natriuretic peptide(BNP) in coronary insufficiency: relationship with left ventricular filling and exercise tolerance[J]. Ann Cardiol Angeiol ( Paris), 1999,48: 523-528.
10LUBIEN E, DeMARIA A, KRISHNASWAMY P, et al. Utility of B-Na-triuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings[J]. Circulation, 2002, 105: 595-601.
2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.
